Found: 8
Select item for more details and to access through your institution.
Systemic inflammation markers and cancer incidence in the UK Biobank.
- Published in:
- European Journal of Epidemiology, 2021, v. 36, n. 8, p. 841, doi. 10.1007/s10654-021-00752-6
- By:
- Publication type:
- Article
The blood proteome of imminent lung cancer diagnosis.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-37979-8
- By:
- Publication type:
- Article
The blood metabolome of incident kidney cancer: A case-control study nested within the MetKid consortium.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Circulating markers of cellular immune activation in prediagnostic blood sample and lung cancer risk in the Lung Cancer Cohort Consortium (LC3).
- Published in:
- International Journal of Cancer, 2020, v. 146, n. 9, p. 2394, doi. 10.1002/ijc.32555
- By:
- Publication type:
- Article
Correction: Comparative performance of lung cancer risk models to define lung screening eligibility in the United Kingdom.
- Published in:
- 2021
- By:
- Publication type:
- corrected article
Comparative performance of lung cancer risk models to define lung screening eligibility in the United Kingdom.
- Published in:
- 2021
- By:
- Publication type:
- journal article
The relationship between blood pressure and risk of renal cell carcinoma.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Lung cancer risk discrimination of prediagnostic proteomics measurements compared with existing prediction tools.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2023, v. 115, n. 9, p. 1050, doi. 10.1093/jnci/djad071
- By:
- Publication type:
- Article